Chemical Financing Hits Record Levels – Young & Partners (ICIS Chemical Business Feb 17, 2017 Issue)
Young & Partners analyzes the record dollar value of debt and equity financing in chemicals
Pharma and Biotech Markets – Challenges and Opportunities (Pharma Exec January 2017 Issue)
Peter Young examines what is happening in the M&A and Equity Financing Markets and the Implications for Management
A Fireside Chat with Dr. Stephen Miller (Pharmaceutical Executive Magazine Nov 30, 2016)
Peter Young interviews Dr. Stephen Miller of Express Scripts about his career and industry thoughts
Chemical Week – M&A Moderates Despite Announced Mega Deals (November 28, 2016)
Editor-in-Chief interviews Young & Partners about M&A market slowdown and shift to Asia
Capital Markets Shift Amid Volatility (ICIS Chemical Business November 21, 2016 issue)
Young & Partners dissects the volatile debt and equity markets, including the Western IPO drought
Creating Value in a Challenging Market (ICIS Chemical Business November 14 – 20, 2016 issue)
Young & Partners article documents the slower and shifting M&A market - contrary to conventional Wisdom
Chemical Capital Market Contradictions (ICIS Chemical Business August 15 – 21, 2016 Issue)
Young & Partners' insights about chemical company valuations, IPOs, and debt markets conditions
Chemical M&A Chaos Continues (ICIS Chemical Business August 1-14, 2016 issue)
Young & Partners reports on what happened in the first half and the outlook for 2016
Pharma and Biotech Financial Outlook – Calm or Crisis (Young & Partners Pharma Exec Article – June 2016 Issue)
Young & Partners examines whether the current slowdown in the M&A and equity financing markets a lull or permanent
Biotech Financial and M&A Trends – Two Steps Forward, One Step Back (Pharmaceutical Executive March 28, 2016)
Young & Partners examines what happened on the Biotech M&A, IPO and financial fronts in 2015 and hat to expect in 2016.